非编码RNAs在卵巢癌早期诊断中的研究进展  

Research progress of non-coding RNAs in early diagnosis of ovarian cancer

作　　者：高宇峰(综述) 王元(审校)[2] Gao Yufeng;Wang Yuan(Wuxi School of Medicine, Jiangnan University,Jiangsu Province,Wuxi 214122, China;不详)

机构地区：[1]江南大学无锡医学院,江苏无锡214122 [2]江南大学附属医院妇产科,214125

出　　处：《疑难病杂志》2022年第6期665-668,共4页Chinese Journal of Difficult and Complicated Cases

基　　金：江苏省妇幼健康科研重点资助项目(F201915);2020年无锡市“太湖人才计划”马丁院士团队(锡人才办[2020]9号);2021年无锡市医学创新团队(CXTD2021023)。

摘　　要：卵巢癌是女性生殖系统中病死率最高的恶性肿瘤,由于卵巢癌早期阶段症状并不明显,发现时大多已经是癌症晚期阶段。早期诊断卵巢癌可以大大提高患者的生存期并改善预后,但目前仍缺少有效的早期诊断方法。非编码RNAs在肿瘤领域的研究受到越来越多的关注。目前已有非编码RNAs作为肿瘤生物标志物的相关报道。文章主要围绕非编码RNAs在卵巢癌早期诊断中的研究进展进行综述。Ovarian cancer is the malignant tumor with the highest mortality rate in the female reproductive system.Because the symptoms of ovarian cancer in the early stage are not obvious,most of them are already in the advanced stage when they are discovered.Early diagnosis of ovarian cancer can greatly improve the survival of patients and improve prognosis,but there is still a lack of effective early diagnosis methods.The research of non-coding RNAs in the field of cancer has received more and more attention.There have been reports of non-coding RNAs as tumor biomarkers.Therefore,this article mainly reviews the research progress of non-coding RNAs in the early diagnosis of ovarian cancer.

关 键 词：卵巢癌 非编码RNAS 诊断 生物标志物 

分 类 号：R737.31[医药卫生—肿瘤]